The federal Project Grant award R01HL171709, in the amount of $772,624.00, was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) on August 1, 2024. The award supports a 5-year observational study to investigate the longitudinal association between post-infarct lipomatous metaplasia (LM) and the incidence of malignant arrhythmia following myocardial infarction (MI). The research aims to define the relationship between reperfusion injury, LM, and ventricular tachycardia, which has implications for improving risk stratification and treatment for patients with prior MI. The study will be conducted by the Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, a renowned private research university and academic medical center.
Generated 1/28/25, 8:22 AM